initial public offerings (IPOs) trading on American exchanges

Thursday, May 18, 2017

G1 Therapeutics (GTHX) began trading on the Nasdaq on 18 May 2017

G1 Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel small molecule therapeutics for the treatment of patients with cancer in the United States.
  • Sector: Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 44
  • Headquarters: Research Triangle Park, North Carolina
  • Founded: 2008

  • One week later:

No comments:

Post a Comment